Company intelligence / Profile preview

CG MedTech

Maryland, USA

Ownership: Private
Employees: ~105
Development stage: Other

Overview

CG MedTech’s marketed devices (such as ANAX 5.5, Velofix TLIF, Excender expandable cage, CGDERM) are recognized globally, have received AATB certification for human tissue safety in the US, and are actively expanding into the US and Latin America with exclusive supply agreements (e.g., NOVOSIS Trauma licensing to Johnson & Johnson MedTech)

Therapeutic areas: OtherNeurology
Modalities: DeviceBiologic3D printed implantHuman tissue graftOrthopedic implant
Industry: Implantable Medical Devices

Partnerships

Johnson & Johnson MedTech (exclusive supply for NOVOSIS Trauma in South Korea)Wake Forest Institute for Regenerative Medicine (R&D and manufacturing partnership, North Carolina)CGBio (strategic investor and parent)

Beyond the preview

Go deeper on CG MedTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CG MedTech.

Explore the full profile